• Home >>
  • Pharmaceuticals and Healthcare >>
  • Oligonucleiotide Synthesis Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Oligonucleiotide Synthesis Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 240211 21st May, 2018 Region : Global Pages Reports Monitor

Oligonucleotide Synthesis Market by Product (Primers, Probes, Reagent, Equipment), by Application (Research, Diagnostics, Therapeutics), by End-User (Pharmaceutical & Biotechnological Companies, Diagnostic Laboratories)-Global Forecast Till 2025


Market Synopsis

Oligonucleotides synthesis is defined as building up smaller chunks of nucleic acid artificially with the help of enzyme chemistry and genetic engineering. These chemically synthesized oligonucleotides are composed of defined chemical structures or sequences in various sizes. They are typically made up of 13 to 25 nucleotides and are constructed to incorporate particularly to DNA or RNA sequences. During the enzymatic process of DNA synthesis, deoxy-ribonucleotide-5’-tri-phosphates are used as substrates in polymerization. Additionally, the process needs to be supplied with a template and primer. As oligonucleotide can be synthesized chemically it has the potential to do the customizations and derive the required sequence online easily and at the required time.  


Growing application of oligonucleotides in therapeutics, diagnostics& drug development, increasing concentration on genomics & genetics in the research & developments and swift growth of life science industry are the vital factors driving the growth of oligonucleotide synthesis market. Rising R&D expenditure in biotechnological and pharmaceutical companies and increasing government investment further boosts the expansion of the market.


However, fluctuating actual price and potential price of synthesized oligonucleotides and lack of cooperative set of regulations for therapeutic oligonucleotides may hamper the growth of the market. Great potential of developing Asian countries provides enhanced opportunities to infiltrate the market. Nevertheless, industrial scale synthesis of oligonucleotides and delivery of oligonucleotide drug to specific targets are the greatest challenge of the market. 


Segmentation

The global oligonucleotide synthesis market is segmented on the basis of product, application, end-user and region. 


Based on product type the market is differentiated into synthesized oligonucleotides, reagents and equipment’s. Synthesized oligonucleotides are further divided into primers, probes, linkers & adopters. 


Application wise the market is categorized into research, diagnostics and therapeutics. Research is further separated into Sequencing, PCR, OPCR, gene synthesis and others. Therapeutics is segmented into nucleic acid aptamers, RNAi, DNA/antisense oligonucleotide and immunotherapy applications.


Depending upon end-user the market is classified into pharmaceutical & biotechnological companies, diagnostic laboratories, academic research institutes and other end-users. 


Regional Analysis

The global oligonucleotide the market is segmented into four major regions: North America, Europe, Asia-Pacific and Latin America, the Middle East & Africa. Pharmaceutical & biotechnological companies strongly engaging R&D, increased expenditure and availability of private and public sectors funds for research activities and presence of key market players drives the growth of the North America followed by Europe. Asia-Pacific oligonucleotide market is promising.  Growth of the region is credited to improvement in healthcare sector, rising investment in life science research, diagnostic advancements in disease treatment, use of sophisticated technologies and emergence of Start-up companies owing to large population base in the region. LAMEA is witnessing sluggish growth due to less development in technology and poor economic conditions. 


Key Players

Major players in the market of oligonucleotide synthesis are Sigma-Aldrich Corporation Thermo Fisher Scientific, Integrated DNA Technologies, Agilent Technologies, GE Healthcare, BioAutomation, Eurofins Genomics, GeneDesign, Eurogentec and GenScript. 


Global Oligonucleotide Synthesis Market Segmentation

• By Product

o Synthesized Oligonucleotides

 Product

 Primers

 Probes

 Linkers & Adopters

o Reagents

o Equipment

• By Application

o Research

 Sequencing

 PCR

 qPCR

 Gene Synthesis

o Diagnostics

o Therapeutics

 Nucleic Acid Aptamers

 RNAi

 DNA/Antisense Oligonucleotide

 Immunotherapy Applications

• By End-User 

o Pharmaceutical & Biotechnological Companies

o Diagnostic Laboratories

o Academic Research Institutes 

o Other End-Users

• By Geography

o North America

 U.S.

 Canada

 Mexico

o Europe

 UK

 Germany

 France

 Italy

 Spain

 Rest of Europe

o Asia-Pacific

 China

 India

 Japan

 South Korea

 Rest of Asia-Pacific

o LAMEA

 Brazil

 Saudi Arabia

 South Africa

 Rest of LAMEA 

• Key Market Players

o Sigma-Aldrich Corporation

o Thermo Fisher Scientific

o Integrated DNA Technologies

o Agilent Technologies

o GE Healthcare

o BioAutomation

o Eurofins Genomics

o GeneDesign

o Eurogentec

o GenScript

Research Scope


 

The study for Global Oligonucleotide Synthesis Market will provide market size, estimates and forecast based on the following years: 

 

Historic data: 2015  Base Year Estimate: 2016  Forecast: 2017 to 2025


The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 


Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 


The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 

 

1. Introduction

1.1. Market Definition

1.2. Market Scope

2. Research Methodology

2.1. Primary Research

2.2. Secondary Sources

2.3. Assumptions & Exclusions

3. Market Overview

3.1. Research Report Segmentation & Scope

3.2. Key Market Trend Analysis

3.2.1. Market Drivers

3.2.2. Market Restraint/Challenges

3.2.3. Market Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Potential Venture Avenues

3.5. Market Share Analysis, 2016 

4. Product Overview

4.1. Introduction

4.2. Market Size & Forecast, 2015 to 2025

4.2.1. Synthesized Oligonucleotides

4.2.1.1. Product

4.2.1.2. Primers

4.2.1.3. Probes

4.2.1.4. Linkers & Adopters

4.2.2. Reagents

4.2.3. Equipment

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

5. Application Overview

5.1. Introduction

5.2. Market Size & Forecast, 2015 to 2025

5.2.1. Research

5.2.1.1. Sequencing

5.2.1.2. PCR

5.2.1.3. qPCR

5.2.1.4. Gene Synthesis

5.2.2. Diagnostics

5.2.3. Therapeutics

5.2.3.1. Nucleic Acid Aptamers

5.2.3.2. RNAi

5.2.3.3. DNA/Antisense Oligonucleotide

5.2.3.4. Immunotherapy Applications

 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

6. End-User Overview

6.1. Introduction

6.2. Market Size & Forecast, 2015 to 2025

6.2.1. Pharmaceutical & Biotechnological Companies

6.2.2. Diagnostic Laboratories

6.2.3. Academic Research Institutes 

6.2.4. Other End-Users

 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

7. Regional Overview

7.1. Introduction

7.2. Market Size & Forecast, 2015 to 2025

7.2.1. North America

7.2.1.1. U.S. 

7.2.1.2. Canada

7.2.1.3. Mexico

7.2.2. Europe

7.2.2.1. UK

7.2.2.2. Germany

7.2.2.3. France

7.2.2.4. Italy 

7.2.2.5. Spain

7.2.2.6. Rest of Europe

7.2.3. Asia-Pacific

7.2.3.1. China

7.2.3.2. India

7.2.3.3. Japan

7.2.3.4. Australia

7.2.3.5. Rest of Asia-Pacific

7.2.4. LAMEA

7.2.4.1. Brazil

7.2.4.2. Saudi Arabia

7.2.4.3. South Africa

7.2.4.4. Rest of LAMEA

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

8. Manufacturer/ Vendor Profile

8.1. The following attributes will be considered while profiling key manufacturers in this industry: 

8.1.1. Company Overview

8.1.2. Financial Synopsis

8.1.3. Recent Developments

8.1.4. R&D Investments (if any)

8.1.5. Strategy Overview (Analyst Perspective)

8.1.6. Product Portfolio

8.2. Companies Profiled

8.2.1. Sigma-Aldrich Corporation

8.2.2. Thermo Fisher Scientific

8.2.3. Integrated DNA Technologies

8.2.4. Agilent Technologies

8.2.5. GE Healthcare

8.2.6. BioAutomation

8.2.7. Eurofins Genomics

8.2.8. GeneDesign

8.2.9. Eurogentec

8.2.10. GenScript

(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.)

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]